We hypothesized that GR antagonism would improve responses to nab-paclitaxel by inhibiting cortisol-mediated cell-survival pathways that would otherwise counteract taxane-induced apoptosis in tumor cells. The gene discussed is NR3C1; the disease is neoplasm.